What is the recommended dosage of aspirin in the treatment of acute coronary syndrome (ACS), and which form of aspirin is preferred?

Updated: May 07, 2019
  • Author: A Maziar Zafari, MD, PhD, FACC, FAHA; Chief Editor: Eric H Yang, MD  more...
  • Print

All patients presenting with ACS should receive nonenteric-coated chewable aspirin in a dose of at least 162 to 325 mg, unless there is a clear history of aspirin allergy. Patients with aspirin intolerance still should receive aspirin at presentation.

Chewable aspirin is preferred, as this promotes rapid absorption into the bloodstream to achieve faster therapeutic levels.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!